Key result
Perioperative anti-obesity medication strategies require specific cessation intervals like holding phentermine for one week.
This corrigendum updates perioperative management guidelines for patients on anti-obesity medications, including revised preoperative cessation intervals and intraoperative glucose monitoring targets.
May inform perioperative cessation strategies for anti-obesity agents; leaves open prospective trials to validate optimal intervals.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kwak et al. (2026) conducted a review in Obesity. Anti-obesity medications was evaluated. Anti-obesity medications require specific perioperative management and preoperative cessation intervals, such as continuing tirzepatide with risk-mitigation or holding phentermine for one week.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: